Asia-Pacific Peptide Therapeutics Market Trends, Size, Competitive Analysis and

Posted by mansi on November 10th, 2020

The Asia-Pacific peptide therapeutics market will see a considerable growth of 6.7% during the forecast period. Asia-Pacific is one of the promising regions in the field of peptides. The frequent collaboration of various global and domestic companies through workshops and seminars is also expected to present a new growth opportunity for the Asia-Pacific peptide therapeutics market. 

‘AsiaTIDES Oligonucleotide & Peptide Therapeutics’ is expected to take place between November 11 to 13, 2020. It is the only event in Asia that is expected to bring together science, technologies, and partners to accelerate oligonucleotide and peptide molecules to market. It offers separate tracks covering the latest oligonucleotide and peptide development strategies from discovery, nonclinical, clinical, and CMC to late-stage development and commercialization.

Request a Free Sample of ourAsia-Pacific Peptide Therapeutics Market:

  • Drug delivery of oligonucleotides, peptides, mRNA, RNA, and CRISPR
  • CMC approaches to accelerate peptide, oligonucleotides, and mRNA therapeutics 
  • The future of peptide vaccines and personalized peptide therapies

Additionally, numerous global companies are also expanding their R&D centers across the region which will also aid the growing shares of the peptide therapeutics market in Asia-Pacific. The global market players are expanding their reach in the merging economies of the region, especially in India, China, Vietnam, and Indonesia. With this expansion, the market for peptide therapeutics is expected to increase in Asia-Pacific during the forecast period. 

A full Report of Asia-Pacific Peptide Therapeutics Market is Available at:

Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment/region dominates the market in the base year?
  • Which segment/region will project the fastest growth in the market during the forecast period?
  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Asia-Pacific Peptide Therapeutics Market – Segmentation

By Route of Administration

  • Oral
  • Parenteral

By Application

  • Cancer
  • Metabolic Disorder
  • Gastrointestinal Disorders
  • Central Nervous System Disorders
  • Respiratory Disorders
  • Others (Kidney Disorder and Autoimmune Disorder)

Asia-Pacific Peptide Therapeutics Market – Segmentation by Geography

  • China
  • Japan
  • India 
  • Rest of Asia-Pacific

Company Profiles

  • Amgen, Inc.
  • Overview
  • Amgen Inc. in Asia-Pacific
  • Amgen Inc. in Peptide Therapeutics Landscape
  • Recent Developments
  • Astellas Pharma Inc.
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Novartis International AG
  • Novo Nordisk A/S
  • Simcere Pharmaceutical Group
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Qingdao Primedicine Pharmaceutical Co. Ltd.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari


Contact no:  +91 7803040404

Like it? Share it!


About the Author

Joined: January 22nd, 2020
Articles Posted: 169

More by this author